Bifidobacterium infantis
Evidence status
Limited evidence to recommend for any consumer outcome yet.
2 papers · 1 claim · 2 outcomes scored
Outcomes
What bifidobacterium infantis actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Less pain, bloating, and unpredictable bowel habits from IBS.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Ease irritable bowel symptoms Not enough research | | 1 meta-analysis n=— Meta-analyzed | — | 6 wk | — |
Sources
Generated August 14, 2026
Related
More evidence for Bifidobacterium infantis
Ingredient evidence
Ingredient evidence
NewAsian Psyllium
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewBacillus Coagulans
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewBifidobacterium (unspecified)
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewPeppermint
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewProbiotics
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewBlonde Psyllium
All scored outcomes
Aug 14, 2026